NCT00855257View on ClinicalTrials.gov

Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Acute Coronary Syndrome (ACS)
Interventions
DRUG

Acid Nicotinique

DRUG

Placebo

Trial Locations (1)

31000

Hôpital de Rangueil, Toulouse

All Listed Sponsors
collaborator

Merck Serono International SA

INDUSTRY

lead

French Cardiology Society

OTHER

NCT00855257 - Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter